<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Windlas Biotech Limited has filed a disclosure with BSE and NSE confirming that it does not fall under the category of 'Large Corporate' as defined under SEBI Circular dated October 19, 2023. The company is making this confirmation for the financial year 2026-27. This means the enhanced disclosure and reporting requirements applicable to Large Corporates under SEBI guidelines do not apply to Windlas Biotech. The company has provided its registered office in Dehradun and corporate office in Gurgaon along with relevant contact details.
This is a routine regulatory compliance filing with no direct impact on the stock. It simply confirms that Windlas Biotech does not meet the thresholds for Large Corporate classification, meaning it avoids the additional disclosure obligations that apply to larger entities.